Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 2, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 8 April 2026 - 15:28

Human medicines European public assessment report (EPAR): Blenrep, belantamab mafodotin, Date of authorisation: 23/07/2025, Revision: 2, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/blenrep

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters